6.0K(top 5%)
publications
122.7K
citations
115(top 5%)
h-index
0.25(top 20%)
e-Score
4.0(top 10%)
2-year impact

Key facts

Human Vaccines and Immunotherapeutics has 6,002 publications and 122,710 citations in exaly, which is 20.4 citations per publication. Its h-index is 115 (2026), in the top 5% of journals that year. Its Score D is 0.25 (2025), in the top 20% of journals that year. Its 2-year impact is 3.97 (2025), in the top 10% of journals that year. Its 5-year impact is 3.79 (2025), in the top 10% of journals that year. Its 10-year impact is 3.54 (2025), in the top 10% of journals that year. Of its publications from 2022 to 2024, 7.3% were in the top 10% most cited of their field and year, where the world's share is 10% (95% interval 6.2–8.7%). Patents cite this work 1,272 times. By its 2-year impact in 2025, it is in Q2 of Immunology (42nd of 139 journals). These quartiles come from exaly's own 2-year impact. Data version: 2026-11-10.

Human Vaccines and Immunotherapeutics 2-Year Impact
This chart shows the 2-Year Impact of Human Vaccines and Immunotherapeutics over time and its percentile among journals.
Download data:JSONCSV
Human Vaccines and Immunotherapeutics: percentile record by year
Each cell is the percentile of Human Vaccines and Immunotherapeutics among all journals in that year: 99 means higher than 99% of them, and darker is higher. Blank means no ranked value that year. Publications, citations and h-index grow with size.
Download data:JSONCSV

How influential is Human Vaccines and Immunotherapeutics in terms of citations?

Based on the citation analysis of 6,002 articles Human Vaccines and Immunotherapeutics has published so far, 8% of its articles have received no citation at all. 346 articles (about 5% of the total articles) have received only one citation. 18.36% of the articles (153) have received over 100 citations.
How to cite this page

exaly, “Human Vaccines and Immunotherapeutics”, data version 2026-11-10, https://exaly.com/journal/15434/human-vaccines-and-immunotherapeutics, licensed under CC BY-SA 4.0.